Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

Volume: 377, Issue: 18, Pages: 1723 - 1732
Published: Nov 2, 2017
Abstract
Spinal muscular atrophy is an autosomal recessive neuromuscular disorder that is caused by an insufficient level of survival motor neuron (SMN) protein. Nusinersen is an antisense oligonucleotide drug that modifies pre–messenger RNA splicing of the SMN2 gene and thus promotes increased production of full-length SMN...
Paper Details
Title
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
Published Date
Nov 2, 2017
Volume
377
Issue
18
Pages
1723 - 1732
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.